AGAP3 and cryptococcosis: Cryptococcal antigen immunoassays have been shown to be effective in identifying patients at risk of developing subclinical cryptococcal infection before ART initiation.2,25 Despite this, there is currently no consensus about how to manage patients who are CrAg +ve.